We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
ChemImpex H-Ala-Phe-Pro-pNA, 201732-35-6; MFCD00237747, 25MG
List Price $122.06 Your Price $122.06
ChemImpex H-Ala-Phe-Pro-pNA; ; 201732-35-6; MFCD00237747 - CMX (Additional S&H or Hazmat Fees May Apply)
NETA PART: CMX-32603-25MG
MFG.PART: 32603-25MG
UNSPSC: 12350000
Manufacturer: Chem Impex International


Specifications
| CAS Number | 201732-35-6 |
| Molecular Formula | C23H27N5O5 |
| Molecular Weight | 453.5 |
| MDL Number | MFCD00237747 |
| PubChem ID | 77245497 |
| Conditions | Store at 2-8 °C |
Safety & Regulations
| Hazmat | No |
| Antibiotic | No |
| DEA-regulated | No |
| Warnings | - |
H-Ala-Phe-Pro-pNA is widely utilized in research focused on:
- Enzyme Activity Assays: This compound serves as a substrate in assays to measure the activity of proteolytic enzymes, helping researchers understand enzyme kinetics and mechanisms.
- Peptide Synthesis: It is used in the synthesis of peptides, allowing for the creation of specific sequences that are crucial in drug development and therapeutic applications.
- Biochemical Research: The compound aids in studying protein interactions and functions, providing insights into cellular processes and disease mechanisms.
- Drug Development: H-Ala-Phe-Pro-pNA is instrumental in screening potential drug candidates, particularly in the development of peptide-based therapeutics.
- Diagnostic Applications: It can be employed in diagnostic assays to detect specific enzyme levels, contributing to the diagnosis of various medical conditions.
| SKU | CMX-32603-25MG |
|---|---|
| Supplier Part Number | 32603-25MG |
| UM | EA |
| UNSPSC | 12350000 |
| Manufacturer | Chem Impex International |
| Temperature | Store at 2-8 °C |
| ProductLine | CMX |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| CAS Number | 201732-35-6 |
| Energy Star | No |
| Green | No |
| Controlled | N |

